Boothbay Fund Management, LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

  • $4.17 Billion
  • Q1 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.99 - $18.71 $20,979 - $39,291
2,100 Added 0.25%
848,800 $15.7 Million
Q2 2023

Aug 14, 2023
BUY
$9.17 - $19.29 $7.76 Million - $16.3 Million
846,700 New
846,700 $9.36 Million
Q1 2022

May 16, 2022
SELL
$13.37 - $17.79 $2.45 Million - $3.27 Million
-183,600 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$14.28 - $19.53 $1.96 Million - $2.68 Million
137,300 Added 296.54%
183,600 $2.99 Million
Q3 2021

Nov 15, 2021
BUY
$12.99 - $20.47 $601,437 - $947,761
46,300 New
46,300 $688,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email